科學家發現腎臟調節水分的隱藏機制
Scientists find a hidden mechanism in how kidneys manage water
Updated at: June 19, 2026 at 04:30 AM
數十年來，科學家一直認為加壓素荷爾蒙是腎臟用來保存水分與濃縮尿液的唯一機制。
For decades, scientists believed that the hormone vasopressin was the sole mechanism kidneys used to conserve water and concentrate urine.
然而，梅奧診所的研究人員近期發現了一條隱藏的、與荷爾蒙無關的備用路徑，這從根本上改變了我們對腎臟生理學的理解。
However, researchers at the Mayo Clinic recently uncovered a hidden, hormone-independent backup pathway that fundamentally changes our understanding of kidney physiology.
這項發表在《臨床調查雜誌》上的開創性發現顯示，一種稱為尿酸的物質會作為信號分子，觸發水分的再吸收。
This groundbreaking discovery, published in the Journal of Clinical Investigation, revealed that a substance called urate acts as a signaling molecule to trigger water reabsorption.
這一突破是在研究多囊性腎病（PKD）時偶然發現的。
The breakthrough occurred by accident while researchers studied polycystic kidney disease (PKD).
他們發現一種名為丙磺舒（probenecid）的舊藥物竟能意外地減緩囊腫生長。
They found that an older medication called probenecid unexpectedly helped slow cyst growth.
目前，多囊性腎病的標準療法涉及阻斷加壓素，這會導致產生過量尿液的副作用。
Currently, standard treatments for PKD involve blocking vasopressin, which leads to the side effect of producing excessive amounts of urine.
透過針對此新發現的尿酸路徑，丙磺舒在早期測試中協助減少了尿液產量，為在不產生現有療法所伴隨之嚴重副作用的情況下，更好地管理腎臟疾病提供了途徑。
By targeting this newly discovered urate pathway, probenecid helped reduce urine production in early tests, offering a path to better manage kidney disease without the severe side effects associated with current therapies.
雖然丙磺舒本身因其對身體的廣泛影響而並非長期解決方案，但此一發現為開發更精準、更具針對性的療法奠定了關鍵基礎，這些療法有望顯著改善全球患者的生活品質。
While probenecid itself is not a long-term solution due to its broad effects on the body, this discovery provides a crucial foundation for developing more precise, targeted treatments that could significantly improve the quality of life for patients worldwide.
